Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 – Strategic Revenue Insights (SRI)

Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...

Johnson & Johnson: RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line ...

Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...

CBSE Class 10 English Exam 2026 LIVE: Sample Paper, PYQs, and other Important Resources to Score High

CBSE Class 10 English Exam 2026 Live updates on exam timing, guidelines, student reactions, answer key, and difficulty level. Check all important details here.